Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $209,400 |
Sells | 6 | $7,289,984 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Mar 2024 16:33 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 06 Mar 2024 | Purchase | 30,000 | 6.98 | 209,400 | D |
26 Feb 2024 19:01 | GKOS | GLAUKOS Corp | FOLEY MARK J | Director | 23 Feb 2024 | Sale | 4,560 | 92.87 | 423,487 | D |
04 Aug 2023 17:07 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 03 Aug 2023 | Sale | 26,279 | 22.5713 | 593,151 | D |
05 Jul 2023 21:11 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 03 Jul 2023 | Sale | 26,279 | 24.9375 | 655,333 | D |
13 Jun 2023 20:09 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 09 Jun 2023 | Sale | 31,279 | 30.7212 | 960,928 | D |
16 May 2023 20:29 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 15 May 2023 | Sale | 70,447 | 34.5469 | 2,433,725 | D |
09 Mar 2023 21:45 | RVNC | Revance Therapeutics Inc | FOLEY MARK J | CEO | 09 Mar 2023 | Sale | 70,390 | 31.5863 | 2,223,360 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)